Issue 17, 2010

Chimeric microtubule disruptors

Abstract

A chimeric approach is used to discover microtubule disruptors with excellent in vitro activity and oral bioavailability; a ligand–protein interaction with carbonic anhydrase that enhances bioavailability is characterised by protein X-ray crystallography. Dosing of a representative chimera in a tumour xenograft model confirms the excellent therapeutic potential of the class.

Graphical abstract: Chimeric microtubule disruptors

Supplementary files

Article information

Article type
Communication
Submitted
08 Feb 2010
Accepted
04 Mar 2010
First published
20 Mar 2010

Chem. Commun., 2010,46, 2907-2909

Chimeric microtubule disruptors

M. P. Leese, F. Jourdan, M. R. Kimberley, G. E. Cozier, N. Thiyagarajan, C. Stengel, S. Regis-Lydi, P. A. Foster, S. P. Newman, K. R. Acharya, E. Ferrandis, A. Purohit, M. J. Reed and B. V. L. Potter, Chem. Commun., 2010, 46, 2907 DOI: 10.1039/C002558E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements